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Agaricus blazei is widely accepted as a traditional medicinal mushroom, and it has been known to exhibit immunostimulatory and
anti-cancer activity. However, the apoptotic mechanism in cancer cells is poorly understood. In this study, we have investigated
whether A. blazei extract (ABE) exerts antiproliferative and apoptotic eﬀects in human leukemic THP-1 cells. We observed
that ABE-induced apoptosis is associated with the mitochondrial pathway, which is mediated by reactive oxygen species (ROS)
generation and prolonged c-Jun N-terminal kinase (JNK) activation. In addition, the ABE treatment resulted in the accumulation
of cytochrome c in the cytoplasm, an increase in caspase activity, and an upregulation of Bax and Bad. With those results in
mind, we found that ABE decreases constitutive NF-κB activation and NF-κB-regulated gene products such as IAP-1 and -2. We
concluded that ABE induces apoptosis with ROS-dependent JNK activation and constitutive activated NF-κB inhibition in THP-1
cells.
1.Introduction
Reactive oxygen species (ROS), such as hydrogen peroxides
(H2O2), hydroxyl radials (•OH), and superoxide anions
(O2
−), are normally generated by the mitochondria and
other intracellular molecules in all aerobes [1]. In general,
the redox status is well balanced by the enzyme and non-
enzyme systems in cells. Oxidative stress occurs when the
criticalbalanceisdisruptedbyexcessROSproductionand/or
antioxidant depletion [2]. Many chemotherapeutic agents
may be selectively toxic to tumor cells because they increase
oxidant stress [3–5]. Increased intracellular ROS levels could
trigger apoptosis by the activation of the mitochondrial-
dependent cell death pathway through the activation of
mitogen-activated protein kinase (MAPK) pathways and the
proapoptotic Bcl-2 proteins Bax or Bad, thus subsequently
inducing mitochondrial membrane permeabilization and
cell death [4–6].
Nuclear factor-kappa B (NF-κB) is a prominent factor in
cell death or survival. Optimal activation of NF-κBr e q u i r e s
phosphorylation of the NF-κB p65 protein by IKK, along
with the activation of a variety of other kinases [7, 8].
Among the target genes, the inhibitors of apoptosis proteins
(IAPs)arebelievedtobecriticalcellsurvivalsignals.Previous
studies have reported that the IAPs bind to caspases and
inhibit apoptosis [9], indicating that down-regulation of
these proteins and the subsequent activation of caspases is
one of the primary mechanisms of apoptosis in various types
of cancer cells [10, 11]. Because NF-κBc a np r o m o t ec e l l
survival and reduction in its activity leads to apoptosis [12–
14], NF-κB-suppressing agents may be potentially useful in
the prevention and treatment of cancer.2 Evidence-Based Complementary and Alternative Medicine
Many natural dietary extracts from mushrooms have
been found to be potent in the treatment of various cancers
[15, 16]. Mixed mushroom extracts might contain diﬀerent
chemotherapeutic properties with more than one mecha-
nism of action, thus possessing a combination of diﬀerent
chemotherapeutic eﬀects. Therefore, it is very important
to identify the combined eﬀects from mixed mushroom
extracts. The basidiomycete mushroom Agaricus blazei has
been traditionally used in health foods as a source for the
prevention of cancer, hyperlipidemia, arteriosclerosis, and
chronic hepatitis. Agaricus blazei extract (ABE) has been
reported to have anti-tumor and anti-mutagenic eﬀects [17–
19]. The intratumoral [20] or oral administration [21]o f
ABE also resulted in the inﬁltration of natural killer (NK)
cells in the tumor sites and increased NK cell activity
in animals. Our previous studies also demonstrated that
ABE induces the phenotypic and functional maturation
of murine bone marrow-derived dendritic cells [22], and
it increases apoptosis through Akt dephosphorylation in
human leukemic U937 and G2/M cell cycle arrest in human
gastric epithelial AGS cells, respectively [23, 24]. Although
numerous studies on the immunostimulatory eﬀects of ABE
have been reported, the cellular and molecular mechanisms
underlying ABE-induced ROS generation and apoptosis are
not clear.
In this study, to further elucidate the abilities of
ABE-induced apoptosis combined with ROS production,
we investigated the eﬀect of ABE on Jun N-terminal
kinase (JNK) activation and NF-κB inhibition in human
leukemic THP-1 cells. We report here that ABE increases
the intracellular ROS level in a time-dependent manner,
and the increase is responsible for its apoptotic eﬀects.
ABE-induced ROS activated JNK, leading to mitochondria-
dependent apoptosis. ABE treatment markedly resulted in
the accumulation of cytochrome c in the cytoplasm, an
increase in caspase activity, and an upregulation of Bax
and Bad. With those results in mind, we found that
ABE suppressed constitutive NF-κB activation and NF-κB-
regulated gene expression in THP-1 cells. Finally, the ABE-
mediated ROS generation closely correlates with the onset of
apoptosis.
2. Methods
2.1. Reagents. Propidium iodide (PI), paraformaldehyde, 3-
(4,5-dimethyl-2-thiazolyl)-2,5-diphnyl-2H-tetrazolim bro-
mide (MTT), and N-acetyl-cysteine (NAC) were pur-
chased from Sigma (St. Louis, MO). 3,3-Dihexyloxacarbo-
cyanine iodide (DiOC6), 2 ,7 -dichloroﬂuorescein diacetate
(DCFDA), and hydroethidine (HE) were purchased from
Molecular Probes (Eugene, OR). SP600125 were obtained
from Calbiochem (San Diego, CA). RPMI 1640 medium
and fetal bovine serum (FBS) were purchased from Invit-
rogen Co. (Carlsbad, CA) and Gibco BRL (Gaithersburg,
MD), respectively. All other chemicals not speciﬁcally cited
here were purchased from Sigma. ABE was prepared as
previously described [23] and was supplied from Dae-
jeon University Oriental Hospital (Daejeon, Republic of
Korea).
2.2. Antibodies. Antibodies for IAP-1, IAP-2, Bax, Bad, Bcl-
2, PARP, caspase-3, caspase-8, caspase-9, p65, p50 and
nucleolin were purchased from Santa Cruz Biotechnology
(Santa Cruz, CA). β-Actin antibody was purchased from
Sigma and antibodies for JNK and phospho (p)-JNK were
purchased from Cell Signaling (Beverly, MA). Cytochrome c
antibody was purchased Chemicon International (Temecula,
CA).
2.3. Cell Culture and Viability Assay. Human leukemic THP-
1 cells were obtained from the American Type Culture
Collection (Manassas, VA) and maintained in RPMI 1640
culture medium containing 10% heat-inactivated FBS and
1%penicillin-streptomycin(Sigma).Cellswereseededat2 ×
105 cellsml−1, treated with ABE, and then incubated for the
indicated time. Cell viability was determined by MTT assay.
2.4. Flow Cytometric Analysis. Cells were ﬁxed in 70%
ethanol overnight at 4◦C. The cells were washed in phos-
phate-buﬀered saline (PBS) with 0.1% BSA. Cells were
incubated with 1Uml−1 of RNase A (DNase free) and
10μgml −1 of PI overnight at room temperature in the dark.
Cells were analyzed using a FACSCalibur ﬂow cytometer
(Becton Dickenson, San Jose, CA), and CellQuest software
(Becton Dickinson) was used to determine the relative DNA
content based on the presence of a red ﬂuorescence.
2.5. Determination of Mitochondrial Membrane Potential.
Mitochondrial membrane potential was monitored by mea-
suring the uptake of DiOC6. Brieﬂy, cells were harvested,
loaded with 50nM DiOC6 at 37
◦C for 30min in the dark,
and then analyzed using a ﬂow cytometer.
2.6. In Vitro Caspase Activity Assay. Activity of caspase-
like protease was measured using a caspase activation kit
according to the manufacturer’s protocol (R&D systems;
Minneapolis, MN). This assay is based on spectrophotomet-
ric detection of the color reporter molecule p-nitroaniline
(pNA), which is linked to the end of the caspase-speciﬁc
substrate. The caspase cleaves the peptide and releases the
chromophore pNA, which can be quantiﬁed spectrophoto-
metrically at a wavelength of 405nm.
2.7. Western Blot Analysis. T o t a lc e l le x t r a c t sw e r ep r e p a r e d
using a PRO-PREP protein extraction solution (iNtRON
Biotechnology; Sungnam, Republic of Korea). For assay of
cytochrome c release, mitochondrial fractions were prepared
using a mitochondria isolation kit for mammalian cells
(Pierce; Rockford, IL) according to the manufacturer’s
instructions. The preparation of cytoplasmic and nuclear
extracts was conducted using the NE-PER nuclear and
cytoplasmic extraction reagents (Pierce). Cell extracts were
separated on 8 or 10% polyacrylamide gels (PAGE), and
then transferred to nitrocellulose membranes using standard
procedures. The membranes were developed using an ECL
reagent (Amersham; Arlington Heights, IL).
2.8. ROS Measurement. Generation of intracellular ROS was
examinedbyﬂowcytometryusingDCFDAforH2O2 andHEEvidence-Based Complementary and Alternative Medicine 3
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Figure 1: Eﬀect of ABE on cell viability and cell death in THP-1 cells. THP-1 cells were seeded at 2 × 105 cellsml−1 and were then treated
with ABE at the indicated concentrations for 24 h. (a) Cell viability was determined by MTT assay. Each point represents the mean ± SD of
three independent experiments. The signiﬁcance was determined by Student’s t-test (
∗P<. 05 versus vehicle control (0)). (b) DNA contents
and (c) annexin-V+ cells were analyzed by ﬂow cytometer. Percentages represents the sub-G0/G1 phase and annexin-V+ cells, respectively.
The results shown are from one representative experiment of three experiments that exhibited similar patterns.
for O2
−. The cells were exposed to 4mgml−1 ABE and/or
10mM NAC for various times, and then treated with 10μM
DCFDA and 2μMH Ef o r3 0m i na t3 7
◦C. Subsequently, the
cells were collected, washed twice with PBS, and analyzed for
DCFDA and HE ﬂuorescence using a ﬂow cytometer.
2.9. Electrophoretic Mobility Shift Assays (EMSA). DNA-
protein binding assays were carried out with a nuclear
extract. Synthetic complementary NF-κB( 5  -AGT TGA
GGG GAC TTT CCC AGG C-3 ) binding oligonucleotides
(Santa Cruz Biotechnology) were 3 -biotinylated using the
biotin 3 -end DNA labeling kit (Pierce) according to the
manufacturer’s instructions.
2.10. Statistical Analysis. All data were derived from at least
three independent experiments. The blots were visualized
with Chemi-Smart 2000 (Vilber Lourmat, Marine; Cedex,
France). Images were captured using Chemi-Capt (Vilber
Lourmat) and transported into Photoshop. Statistical analy-
seswereconductedusingSigmaPlotsoftwareandvalueswere
presented as mean ± SD. Signiﬁcant diﬀerences between
the groups were determined using the unpaired Student’s t-
test. A value of
∗P<. 05 was accepted as an indication of
statistical signiﬁcance.
3. Result
3.1. ABE Decreases Cell Viability and Induces Apoptosis in
THP-1 Cells. To determine the eﬀect of ABE on cell viability,
human leukemic THP-1 cells were treated with increasing
concentrations up to 4mgml−1 and incubated for 24h. Cell
viability was examined using MTT assays. As shown in4 Evidence-Based Complementary and Alternative Medicine
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Figure 2: Eﬀect of ABE on mitochondrial function and ROS generation. THP-1 cells were seeded at 2 × 105 cells ml−1 and were then treated
with 4 mg ml−1 of ABE for the indicated time. (a) The mitochondrial membrane potential was determined by ﬂow cytometer using DiOC6
labeling of mitochondria. (b) The redox status was monitored by the oxidation-sensitive ﬂuorescent dyes for H2O2 (DCFDA) and O
−
2 (HE).
The results shown are from one representative experiment of three experiments that showed exhibited similar patterns.
Figure 1(a), ABE treatment resulted in a dose-dependent
inhibition of viability in THP-1 cells. Indeed, to elucidate the
ability of ABE in its anti-viable activity, we analyzed cell cycle
distribution using ﬂow cytometry. As shown in Figure 1(b),
ABE caused a signiﬁcant increase in the fraction of sub-
G0/G1 phase in a dose-dependent manner. For example, as
compared with control, the percentage of cells in sub-G0/G1
phase was increased more than 10-fold upon treatment with
4mgml −1 ABE for 24h. Analysis of cell cycle distribution
suggests that ABE treatment might cause apoptosis in THP-
1 cells. Therefore, we further examined the apoptosis-
inducing eﬀect of ABE by annexin-V analysis. As shown in
Figure 1(c), ABE treatment caused signiﬁcant increases in
apoptotic cell percentages as compared with control cells
(17% of apoptotic cells in cells with 4mgml−1 ABE for 24h).
Therefore, we observed that the proliferation of THP-1 cells
was signiﬁcantly suppressed with an increase of apoptotic
percentage in the presence of ABE.
3.2. Mitochondria-Dependent Pathways Are Involved in ABE-
Induced Apoptosis. To further characterize whether ABE
induces apoptosis by triggering the mitochondrial apoptosis
pathway,weinvestigatedthedepolarizationofthemitochon-
drial membrane potential and the generation of ROS. When
the THP-1 cells were exposed to 4mgml−1 ABE up to 24h,
the mitochondrial membrane potential was signiﬁcantly
reduced in a time-dependent manner as evidenced by an
increase in the proportion of cells with lower ﬂuorescence
intensity (Figure 2(a)). As shown in Figure 2(b),t r e a t m e n t
with 4mgml−1 ABE also signiﬁcantly increased the intensity
of DCFDA and HE ﬂuorescence (indicating quantiﬁcation of
peroxides and superoxides, resp.).Evidence-Based Complementary and Alternative Medicine 5
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Figure 3: Eﬀect of ABE on expression of apoptotic proteins. THP-1 cells were seeded at 2 × 105 cells ml−1 and were then treated with 4
mg ml−1 of ABE for the indicated time. (a) Total cell extracts resolved by SDS–PAGE, transferred to nitrocellulose, and probed with speciﬁc
antibodies (a) anti-Bax, anti-Bad and anti-Bcl-2; (d) anti-caspase-3, anti-caspase-8, anti-caspase-9 and anti-PARP). (b) Equal amounts
of mitochondria and cytosol cell lysates were resolved by SDS–PAGE, transferred to nitrocellulose, and probed with a speciﬁc antibody
for cytochrome c. Equal protein loading was evaluated by β-actin. The results shown are from one representative experiment of three
experiments that exhibited similar patterns. (c) Caspase (-3, -8 and -9) activities were determined using caspase assay kits. Each point
represents the mean ± SD of three independent experiments. The signiﬁcance was determined by Student’s t-test (
∗P<. 05 versus vehicle
control (0)). Cyto, Cytoplasm; Mito, Mitochondria.
We next monitored the activation of caspases and the
expression of the pro- and anti-apoptotic proteins. Western
blot analysis showed that treatment with 4mgml−1 ABE
signiﬁcantly increased pro-apoptotic proteins Bax and Bad,
and showed the steady presence of the anti-apoptotic protein
Bcl-2 over the course of time (Figure 3(a)). In addition, ABE
caused cytochrome c to be released from the mitochondria
into the cytosol in a time-dependent manner (Figure 3(b)).
We also examined the eﬀect of ABE on caspase activity, as
well as cleavage of caspases and PARP in THP-1 cells treated
with 4mgml−1 of ABE. As expected, caspase-9 activity
was signiﬁcantly increased (Figure 3(c)), as ABE induces
cytochrome c release into the cytosol (Figure 3(b)). Our
results were also showed increased activation of caspase-8
and -3 (Figure 3(c)). As shown in Figure 3(d), the cleavages
of caspase and PARP revealed in a time-dependent manner.
These ﬁnding indicate that ABE-induced apoptosis was
mediated with the mitochondrial pathway.
3.3. Inhibition of ROS Generation Blocks ABE-Induced Apop-
tosis. To investigate whether ROS generation is directly
associated with ABE-induced mitochondria dysfunction
and apoptosis, we assessed these events in THP-1 cells
pretreated with NAC (10mM) for 2h followed by treatment
with 4mgml−1 ABE. As expected, pretreatment with NAC
decreased ROS generation and normalized mitochondrial
dysfunction caused by ABE in THP-1 cells (Figure 4(a)).
To next determine whether pretreatment with NAC could
block ABE-induced apoptosis, we performed cell cycle
analysis using ﬂow cytometry. As shown in Figure 4(b),
ABE caused a signiﬁcant increase in the fraction of sub-
G0/G1 phase,butNACpretreatmentreversedit.Forexample,6 Evidence-Based Complementary and Alternative Medicine
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Figure 4: The role of ROS on ABE-mediated apoptosis. THP-1 cells (2 × 105 cells ml−1) were pretreated with 10 mM NAC, and then 4 mg
ml−1 of ABE was treated for 12 h (a) and 24 h (b–d). (a) The redox status was monitored by the oxidation-sensitive ﬂuorescent dyes for
O2
− and H2O2. The mitochondrial membrane potential was also determined by ﬂow cytometer using DiOC6 labeling of mitochondria. (b)
DNA contents were analyzed by ﬂow cytometer. The sub-G0/G1 DNA fractions, indicating apoptosis, were determined as a percentage of
the total number of cells. (c) Equal amounts of cell lysate were resolved on SDS-PAGE, transferred to nitrocellulose membranes, and probed
with speciﬁc antibodies for cytochrome c,B a x ,a n dP A R P .β-Actin was used as an internal loading control. (d) THP-1 cells were collected
following 24 h exposure to 4 mg ml−1 of ABE with or without 2 h of pretreatment with NAC. Caspase-3 activity was determined following
the manufacturer’s protocol. Each point represents the mean ± SD of three independent experiments. The signiﬁcance was determined by
Student’s t-test (
∗P<. 05 versus vehicle control). Cyto, Cytoplasm.
as compared with control, the percentage of cells in sub-
G0/G1 phase was increased than 10-fold upon treatment
with 4mgml−1 ABE for 24h, but only increased more
than 3-fold upon pretreatment with NAC. Figure 4(c) also
shows that NAC decreased ABE-mediated Bax expression,
cytochrome c release and PARP cleavage in ABE-treated
THP-1 cells. In addition, the activation of caspase-3 induced
by ABE was markedly attenuated by pretreatment with NACEvidence-Based Complementary and Alternative Medicine 7
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Figure 5: The role of JNK activation on ABE-mediated apoptosis. THP-1 cells (2 × 105 cells ml−1) were treated with 4 mg ml−1 of ABE for
theindicatedtime.(a)EqualamountsofwholecelllysateswereresolvedbySDS-PAGE,transferredtonitrocelluloseandprobedwithspeciﬁc
antibodies against p-JNK and JNK. (b) THP-1 cells were pretreated with 10 mM NAC and then 4 mg ml−1 of ABE was treated up to 24 h.
Then, the cells were lysated and western blot was performed using anti-p-JNK and anti-JNK antibodies. THP-1 cells were pretreated with
SP600125 (20μM) for 2h followed by ABE treatment (4mgml−1) for 24h. At the end of experiments, (c) DNA content and (d) annexin-V
were analyzed by ﬂow cytometer. SP, SP600125.
(Figure 4(d)). These results suggest that the production of
ROS plays an important role in ABE-mediated mitochon-
drial apoptotic pathways.
3.4. JNK Activation Is a Potential Target in ABE-Induced
Apoptosis. As it has been shown that the ROS-mediated
DNA damage triggers activation of JNK and subsequent cell
death [4–6], we examined the status of JNK phosphorylation
after ABE treatment. As shown in Figure 5(a),a c t i v a t i o n
(phosphorylation) of JNK was signiﬁcantly induced in a
time-dependentmannerandpersistedforthedurationofthe
experiment. On the other hand, the constitutive expression
ofJNKwasnotaﬀectedbyABEtreatment.Tofurtheranalyze
whetherABE-inducedROSgenerationisresponsibleforJNK
activation, cells were pretreated with NAC and then exposed
to ABE up to 24h. As shown in Figure 5(b), pretreatment
with NAC prevented the increased phosphorylation of JNK
caused by ABE. To further analyze whether activation of JNK
is responsible for ABE-induced apoptosis, we exposed it to
20μM of SP600125, a JNK1/2 inhibitor for 2h, followed
by treatment with 4mgml−1 of ABE for 24h. As shown in
Figures5(c)and5(d),pretreatmentofSP600125signiﬁcantly
suppressed ABE-induced sub-G0/G1 cell population and
annexin-V+ cells. These data conﬁrm that treatment with
ABE increases the production of ROS, leading to the
activation of JNK.
3.5. ABE Inhibits Constitutive NF-κB Activation and NF-
κB-Dependent IAPs. Because NF-κB activation inhibits pro-
longed JNK activation and prevents the accumulation of
ROS [25, 26], we examined the eﬀect of ABE on the
constitutive DNA-binding activity of NF-κB and the NF-κB-
dependent responsive genes. First, THP-1 cells were treated
with 4mgml−1 ABE over increasing time periods, and we
then performed EMSA. As shown in Figure 6(a),t r e a t m e n t
with ABE inhibited constitutive NF-κB binding activity in
a time-dependent manner. The level of NF-κB inhibition at
24h exposure of ABE was found to be almost completely
inhibited. A similar inhibitory eﬀect of ABE on constitutive
NF-κB binding activity at the 12h time point was observed
inadose-dependentstudy(Figure 6(b)).Next,weconﬁrmed
the eﬀect of ABE on constitutive NF-κB activation in THP-18 Evidence-Based Complementary and Alternative Medicine
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Figure 6: Eﬀe cto fA B Eo nc o n s ti t u ti v eN F - κBa ct i v a t i o ni nT H P - 1c e ll s .T H P - 1c e ll s( 2× 105 cells ml−1) were incubated at 37
◦C with (a) the
indicated time duration of 4mgml−1 of ABE and (b) the indicated concentrations at 12h. DNA-binding activity of NF-κB was analyzed by
lightShift
TM chemiluminescent EMSA kit. (c) Western blots were performed for p65 and p50 protein levels in the nuclear extract. Nucleolin
was used as an internal loading control. (d) Expression of IAP-1and -2was detected via western blot analysis. β-Actinwas usedas aninternal
loadingcontrolforcytoplasm.Theresultsshownarefromonerepresentativeexperimentofthreeexperimentsthatexhibitedsimilarpatterns.
cells by western blot analysis. As shown in Figure 6(c),A B E
treatment resulted in a time-dependent decrease in protein
levels of p65 and p50 in the nuclear extract.
Finally, we investigated whether ABE inhibits the NF-
κB-dependenttranscriptionalactivatedIAPs.Treatmentwith
4mgml −1 of ABE was examined for the expression of these
genes via western blot analysis. As shown in Figure 6(d),
treatment with ABE decreased the expressions of IAP-1 and
-2 in a time-dependent manner, which is consistent with a
decrease in NF-κB activity. Therefore, it is possible that the
induction of THP-1 cell apoptosis by ABE may be due to the
inhibition of various anti-apoptotic factors.
4. Discussion
The present study reveals that ABE induced apoptosis
through ROS-dependent JNK activation and inhibition of
constitutively activated NF-κB in human leukemic THP-1
cells. The ABE-induced ROS generation and activation of
JNK that are associated with apoptotic cell death are signiﬁ-
cantly suppressed by pretreatment with NAC, indicating that
ROS are the upstream-regulators of JNK activation during
ABE-induced apoptosis. Based on the results of the present
study, the mechanism by which ABE induces apoptosis in
THP-1 cells is summarized in Figure 7.
Enhancement of ROS production has been associated
with the apoptotic response induced by various chemother-
apeutic agents [3–5]. ROS can cause apoptotic cell death
via a variety of mechanisms, among which the activation
of JNK plays a key role. It is identiﬁed by several reports
indicating tumor necrosis factor-induced ROS production is
responsibleforsustainedJNKactivationinNF-κB-activation
deﬁcient cells [25–27]. Here, we show that ROS production
in ABE-treated human leukemic THP-1 cells is markedly
increased and functionally linked to JNK activation during
apoptosis via the mitochondrial-dependent pathway. We
further observed that an antioxidant NAC can regulate ROS
detoxiﬁcation, which inhibits JNK activation and decreases
apoptosis induced by ABE. These results suggest that ROS
accumulation contributes to ABE-induced cell death.
JNK, a stress-activated protein kinase, is activated by
many stress stimuli such as UV and ionizing irradiation,
heat shock, cycloheximide, anti-cancer agents and pro-
inﬂammatory cytokines, all of which can induce apoptosis
[28, 29]. How activated JNK contributes to cell death is not
clearly deﬁned, but the production of tBid, a proteolytic
fragment of Bid that speciﬁcally induces the release of mito-
chondrial Smac, points to JNK’s role in JNK in promoting
the initiation of the mitochondrial pathway of apoptosis
[26]. Activated JNK has been also shown to phosphorylateEvidence-Based Complementary and Alternative Medicine 9
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Figure 7: Proposed mechanisms for the apoptotic eﬀects of ABE
in THP-1 cells. The apoptotic mechanism was mediated by the
generationofROS,phosphorylationofJNK,releaseofcytochromec
into cytoplasm, and activation of caspases. Additionally, expression
of IAPs, which have inhibitory eﬀect of caspases, was abolished by
inhibition of NF-κB.
Bcl-2 and Bcl-xL, thereby inactivating their anti-apoptotic
functions [26]. Whereas previous studies presented that NF-
κB activation promotes cell survival by up-regulating the
anti-apoptoticproteins’expression,includingBcl-2aswellas
IAP families, and down-regulating the ROS-dependent JNK
activation through suppression of the ROS accumulation
[27, 30]. NF-κB activation can also maintain tumor cell
viability, and inhibiting NF-κB activation alone can be
suﬃcient to induce cell death [31, 32]. In addition, the
involvement of NF-κB in chemoresistance may be related to
its constitutive activation, such as human acute myelogenous
leukemic cells [33]. Therefore, we used human leukemic
THP-1 cells in this experiment as a model. Several reports
have shown that NF-κB inhibitors act as potent enhancers
of chemotherapy-induced apoptosis [34]. In agreement with
previous ﬁndings, ABE signiﬁcantly inhibited constitutive
NF-κBa c t i v a t i o nin vitro.N F - κB-dependent IAP-1 and -2
werealsosuppressedinABE-treatedcells.Thesedataindicate
that ABE-induced NF-κB inhibition enhances the apoptosis
in ABE-treated cells, because decreased NF-κBa c t i v i t yc o u l d
not prevent ABE-induced ROS-dependent sustained JNK
activation.
In conclusion, our data indicate that human leukemic
THP-1 cells are highly sensitive to growth inhibition and
apoptosis induction by ABE. ABE-induced apoptosis is
associated with the mitochondrial pathway, and they are
mediated by ROS generation and prolonged JNK activation.
Taken together, ABE inhibits constitutive NF-κB activity and
NF-κB-dependent IAP-1 and -2.
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